Sunday, March 16, 2025 | 09:33 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Glenmark receives US FDA nod for anti-inflammatory drug indomethacin

Indomethacin extended-release capsule (75 mg) is generic version of Iroko Pharmaceuticals' Indocin

Glenmark office
Premium

Glenmark office

BS B2B Bureau Mumbai
Glenmark Pharmaceuticals has been granted final approval by the US Food & Drug Administration (FDA) for indomethacin extended-release capsule (75 mg), the generic version of Indocin SR capsule of Iroko Pharmaceuticals LLC. Indomethacin is a non-steroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation.

According to IMS Health sales data for the 12 month period ending April 2017, the Indocin SR extended-release capsule (75 mg) market achieved annual sales of approximately $ 6.3 million.

Glenmark’s current portfolio consists of 118 products authorised for distribution in the US marketplace and 67 ANDA’s pending approval

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in